Pliant Therapeutics, Inc. (PLRX) NASDAQ

1.48

-0.005(-0.34%)

Updated at October 01 10:50AM

Currency In USD

Valuation

Market Cap797.29M
Enterprise Value786.3M
P/E Ratio-0.44
PEG Ratio-0.08
Price/Sales Ratio39.89
Price/Book Ratio0.41
Enterprise/Revenue14.86
Enterprise/EBITDA-0.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-91.17
Operating Margin-96.86

Management Effectiveness

Return On Assets-0.69
Return On Equity-0.73

Income Statement

Revenue0
Revenue/Share0.04
Gross Profit-2.13M
EBITDA-228.37M
Net Income-210.3M
Diluted EPS-3.47

Balance Sheet

Total Cash262.87M
Total Cash/Share4.28
Total Debt30.02M
Total Debt/Equity0.14
Current Ratio12.99
Book Value Per Share3.59

Price History

52-Week Change-86.02
52-Week High16.1
52-Week Low1.1
Moving Average 50 Days1.58
Moving Average 200 Days3.7

Statistics

Average Volume915,460
Shares Outstanding61.39M
% Held by Institutions83.88

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A